How Boudreaux was paid
$22.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|---|
| Gail BoudreauxPresident and Chief Executive Officer (CEO) | $1,600,000 | $13,440,277 | $4,199,765 | $2,768,000 | — | $574,272 | $22,582,314 |
| Mark KayeEVP and Chief Financial Officer (CFO) | $938,462 | $4,560,511 | $1,424,506 | $974,123 | — | $94,475 | $7,992,077 |
| Peter HaytaianEVP and President, Carelon and CarelonRx | $950,000 | $3,840,306 | $1,199,710 | $986,100 | — | $122,372 | $7,098,488 |
| Felicia NorwoodEVP and Chief Health Benefits Officer | $950,000 | $3,840,306 | $1,199,710 | $986,100 | — | $97,849 | $7,073,965 |
| Morgan KendrickEVP and President, Commercial and Specialty Health Benefits | $888,462 | $3,600,237 | $1,124,813 | $922,223 | $23,417 | $102,759 | $6,661,911 |
What changed and why
- $22.6MCEO total compensation increased to $22,582,314 in 2025 compared to $20,471,976 in 2024.
- $197.6BOperating revenue reached $197.6 billion, representing a 13% increase over 2024.
- 86.5%Annual incentive plan awards were funded at 86.5% of target based on company performance.
- 92%Shareholders overwhelmingly approved the advisory executive compensation vote with approximately 92% support.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.